Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

AMP-303 safely increases hair growth in men with hair loss.

Long-term high-dose fluconazole can cause reversible hair loss.

Ebastine may help regrow hair in alopecia areata patients.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Mixing platelet-rich plasma with triamcinolone acetonide can potentially improve hair regrowth in alopecia areata patients.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

People from iodine-deficient areas are more likely to develop hypothyroidism when treated for multi-drug resistant tuberculosis.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Baricitinib significantly improves nail and hair symptoms in severe alopecia areata.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Para-aminobenzoic acid in hair supplements can cause autoimmune hepatitis.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Nanocarriers with spironolactone and 2-deoxy-D-ribose may improve hair loss treatment by targeting hair follicles directly.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Taking cyproterone acetate and ethinyl oestradiol for hair loss can lower vitamin B12 levels in women.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Pulsed electric field treatment may help shrink untreated liver tumors.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

The silk fibroin hydrogel with FGF-2-liposome can potentially treat hair loss in mice.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.